Advanced BioPhotonics enters trial agreement with Beth Israel Deaconess:
This article was originally published in Clinica
Imaging firm Advanced BioPhotonics has entered into a pilot research agreement with the Beth Israel Deaconess Medical Center (BIDMC) - a teaching hospital of Harvard Medical School. As part of the agreement, BIDMC will be carrying out a clinical trial of the company's patented BioScanIR system, which it says provides a fast, noninvasive, radiation-free method for detecting diseases that affect perfusion and reperfusion in human tissue. The first phase of the trial is scheduled to begin in September 2007, said the Bohemia, New York-based company. The BioScanIR system uses the firm's proprietary DIRI - dynamic infrared imaging - technology, which has been developed for detecting and assessing pigmented lesions of the skin including melanoma and other forms of skin cancer.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.